These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 331818)

  • 1. Cardiac transplantation at Stanford.
    Copeland JG; Stinson EB; Griepp RB; Shumway NE
    Acta Chir Belg; 1977; 76(3):387-92. PubMed ID: 331818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac transplantation: review of seven years' experience.
    Schroeder JS; Rider AK; Stinson EB; Shumway NE
    Transplant Proc; 1976 Mar; 8(1):5-8. PubMed ID: 769266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cardiac transplantation. The Stanford experience.
    Sarris GE; Smith JA; Bernstein D; Griffin ML; Pitlick PT; Baum D; Billingham ME; Oyer PE; Stinson EB; Starnes VA
    Circulation; 1994 Nov; 90(5 Pt 2):II51-5. PubMed ID: 7955282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited utility of endomyocardial biopsy in the first year after heart transplantation.
    Hamour IM; Burke MM; Bell AD; Panicker MG; Banerjee R; Banner NR
    Transplantation; 2008 Apr; 85(7):969-74. PubMed ID: 18408576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.
    Foerster A; Simonsen S; Frøysaker T
    APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil.
    Sarris GE; Mitchell RS; Billingham ME; Glasson JR; Cahill PD; Miller DC
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):841-54; discussion 854-5. PubMed ID: 2657223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up and complications after cardiac transplantation.
    Conrad SA; Chhabra A; Vay D
    J La State Med Soc; 1993 May; 145(5):217-20, 223-5. PubMed ID: 8340685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of acute cardiac allograft rejection.
    Oyer PE; Stinson EB; Bieber CP; Reitz BA; Raney AA; Baumgartner WA; Shumway NE
    Transplant Proc; 1979 Mar; 11(1):296-303. PubMed ID: 377648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac transplantation for endstage heart disease.
    Argenziano M; Michler RE; Rose EA
    Heart Vessels; 1997; Suppl 12():23-7. PubMed ID: 9476536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft.
    Milano A; Caforio AL; Livi U; Bauce B; Angelini A; Casarotto D; Thiene G
    J Heart Lung Transplant; 1996 May; 15(5):456-60. PubMed ID: 8771500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathology of heart allograft rejection.
    Winters GL
    Arch Pathol Lab Med; 1991 Mar; 115(3):266-72. PubMed ID: 2001167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in heart and heart-lung transplantation.
    Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
    Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation: a review.
    Oaks TE; Wallwork J
    Br J Biomed Sci; 1993 Sep; 50(3):200-11. PubMed ID: 8241836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
    Imakita M; Tazelaar HD; Billingham ME
    J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.